What is JBIO's financing cash flow?

JBIO (JBIO) reported financing cash flow of -$795K in Q1 2026.

How has JBIO's financing cash flow changed year-over-year?

JBIO's financing cash flow decreased by 13.6% year-over-year, from -$700K to -$795K.

What is the long-term trend for JBIO's financing cash flow?

Over 3 years (2021 to 2025), JBIO's financing cash flow has grown at a 23.7% compound annual growth rate (CAGR), from $190.71M to $360.77M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

JBIO JBIO Financing Cash Flow

Financing Cash Flow at other companies

Vertex PharmaceuticalsVRTX

-$538.8M+20.8%

Travere Therapeutics, Inc.TVTX

$4.2M+13.1%

Vera TherapeuticsVERA

$3.94M+157%

AnaptysBio, Inc.ANAB

$1.21M+104%

Avalo TherapeuticsAVTX

$1.4M—

Cullinan Therapeutics, Inc.CGEM

$380K—

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's financing cash flow?: JBIO (JBIO) reported financing cash flow of -$795K in Q1 2026.
How has JBIO's financing cash flow changed year-over-year?: JBIO's financing cash flow decreased by 13.6% year-over-year, from -$700K to -$795K.
What is the long-term trend for JBIO's financing cash flow?: Over 3 years (2021 to 2025), JBIO's financing cash flow has grown at a 23.7% compound annual growth rate (CAGR), from $190.71M to $360.77M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.